These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [How to prescribe and monitor treatment with hypolipidemic drugs]. Basdevant A, Soffer M. Rev Prat; 1983 Nov 24; 33(54):2967-71. PubMed ID: 6665480 [No Abstract] [Full Text] [Related]
7. [Why does adequate tolerance of a lipid-lowering agent play such an important role?]. Mutschler E. Fortschr Med; 1990 Nov 24; 108 Spec No 1():54-5. PubMed ID: 2245962 [No Abstract] [Full Text] [Related]
8. [Cost-benefit analysis of the therapy of lipid metabolism disorders]. Karádi I. Orv Hetil; 1996 May 26; 137(21):1164. PubMed ID: 8757110 [No Abstract] [Full Text] [Related]
10. [Management of hyperlipemia. When to administer agents that regulate lipid disorders?]. Cybulska B. Kardiol Pol; 1991 May 26; 35(8):107-15. PubMed ID: 1942755 [No Abstract] [Full Text] [Related]
16. Drug treatment of lipid disorders. Broeders N, Knoop C, Abramowicz D. N Engl J Med; 1999 Dec 23; 341(26):2020-1. PubMed ID: 10617402 [No Abstract] [Full Text] [Related]
17. Lipid-lowering drugs: French prescribers under pressure. Prescrire Int; 2002 Oct 23; 11(61):158. PubMed ID: 12378750 [No Abstract] [Full Text] [Related]
18. [Which lipid class for which lipid disorder?]. Wasielewski S. Med Monatsschr Pharm; 2000 Mar 23; 23(3):94-6. PubMed ID: 10741073 [No Abstract] [Full Text] [Related]